Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 2020: Edoxaban for Elderly AF Patients — Dr Ken Okumura
Author(s): Ken Okumura Added: 3 years ago
Dr Ken Okumura (Saiseikai Kumamoto Hospital, Kumamoto, JP) discusses the rationale and results behind ELDERCARE-AF, which investigates low dose Edoxaban for elderly Japanese AF patients ineligible for standard anticoagulant therapy. Questions: 1. What is the rationale for this study? 2. What were the objectives of this study, and its design? 3. What patients were included in the study? 4. What… View more

Anticoagulation

Electrophysiology & Arrhythmia
Unexplained Syncope & Response To Ajmaline in the Elderly
Author(s): Giulio Conte , Pier D Lambiase , Angelo Auricchio Added: 3 years ago
In this video presentation and discussion, Prof Angelo Auricchio (Cardiocentro Ticino, Switzerland) and Prof Pier Lambiase (Barts Heart Centre, London, UK) meet with Dr Giulio Conte to discuss hisrecently published case study on Arrhythmia Academy. They examine and discuss the issues surrounding the unusual presentation in this real-life case as experienced by Dr Conte. They review the… View more

Electrophysiology & Arrhythmia
Implantable Cardiac Electronic Devices in the Elderly Population
Author(s): Wei-Yao Lim , Sandeep Prabhu Added: 3 years ago
The number of cardiac implantable electronic devices (CIED) has been increasing year-on-year.1 This, coupled with improvements in life expectancy,2 means that more elderly patients will meet the criteria for a CIED. National and international guidelines set out clear criteria and make recommendations for CIED use based on available evidence.3–6 However, the majority of clinical trials include few… View more

Electrophysiology & Arrhythmia
ESC 23: MULTISTARS AMI Trial
Author(s): Linda Joosten Added: 7 months ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial. FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists … View more

Anticoagulation

Demographic
Cryoballoon Ablation of Atrial Fibrillation in Octogenarians
Author(s): Tauseef Akhtar , Ronald Berger , Joseph E Marine , et al Added: 3 years ago
AF is a common and clinically impactful arrhythmia. Given both the association of AF with aging and the increasing number of elderly people in the general population, it follows that many AF patients are of advanced age. The management of AF in the geriatric population is associated with several challenges, including multiple comorbidities, increased toxicity of antiarrhythmic drugs (AAD), an… View more

Electrophysiology & Arrhythmia
John McNeill
Job title: Professor and head of School of Public Health and Preventive Medicine
After graduating in medicine from the University of Adelaide Professor McNeil undertook specialist training to become qualified as a consultant in internal medicine and clinical pharmacology. He completed a PhD in Clinical Pharmacology at Melbourne University and was awarded a National Heart Foundation overseas postgraduate research scholarship to study epidemiology at the London School of… View more
Job title: Cardiologist
ProfPasquale Perrone-Filardi is a cardiologist atUniversità degli Studi di Napoli Federico II, Napoli, IT. He is specialised in Cardiology. View more
Prof. Ken Okumura served as a Professor of Medicine at Hirosaki University School of Medicine from 1996 to 2016. He also served as a President of the Japanese Heart Rhythm Society (JHRS) from 2012 to 2016. He is now working at Saiseikai Kumamoto Hospital Cardiovascular Center, Japan, while providing the latest interventional treatments for cardiac arrhythmias especially catheter ablation of AF… View more
Michael Fu
Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Professor Michael Fu is currently a nucleus member of working group of heart failure with preserved ejection fraction, Heart Failure Association, European Society of Cardiology, and an nucleus member of the National Working Group of Heart Failure in Sweden. Michael Fu is an expert in heart failure with research focus on epidemiology, clinical phenotype, prognosis and its risk factors,… View more